Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P2ET
|
||||
| Former ID |
DNC009466
|
||||
| Drug Name |
Garveatin E
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528499] | ||
| Formula |
C20H20O5
|
||||
| Canonical SMILES |
CCC1=C(C(=O)C2=CC3=C(C(=C(C(=O)C3(C)C)C)O)C(=C2C1=O)O)C
|
||||
| InChI |
1S/C20H20O5/c1-6-10-8(2)15(21)11-7-12-14(18(24)13(11)17(10)23)16(22)9(3)19(25)20(12,4)5/h7,22,24H,6H2,1-5H3
|
||||
| InChIKey |
XUTUGWZITVPISM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Indoleamine 2,3-dioxygenase | Target Info | Inhibitor | [528499] | |
| PathWhiz Pathway | Tryptophan Metabolism | ||||
| Reactome | Tryptophan catabolism | ||||
| References | |||||